Hepatocellular Carcinoma on Cirrhosis With Child A/B7 and Hepatic Intra Arterial Injection of Idarubicin/Lipiodol Emulsion

This trial is studying a treatment that delivers chemotherapy directly into the liver's blood supply for people who have liver cancer (hepatocellular carcinoma) that cannot be surgically removed. **You may be eligible if...** - You have been diagnosed with liver cancer (confirmed by biopsy or imaging) - Your liver function is relatively preserved (Child-Pugh A or B7 score) - Your cancer cannot be removed by surgery, ablation, or other local treatments - You are in reasonably good physical condition (ECOG performance status 0 or 1) - You are 18 years or older - You have not previously received chemotherapy, radiation, or other liver-directed treatments for this cancer **You may NOT be eligible if...** - You have already received chemotherapy, radiation, or liver-directed treatments for this cancer - Your liver function is severely impaired (Child-Pugh C) - You have very low platelet counts (below 50,000) - Your overall health makes you unsuitable for the procedure Talk to your doctor to see if this trial is right for you.